Geriatric Oncology

Top Story

Polypharmacy management among older adults with cancer requires multipronged approach

Polypharmacy management among older adults with cancer requires multipronged approach
HemOnc Today, March 10, 2020
Jai N. Patel, PharmD BCOP, CPP
Meeting News

Older allogeneic HSCT recipients receive as many potentially inappropriate medications as younger counterparts

March 6, 2020
ORLANDO — Individuals aged 65 years or older received potentially inappropriate medications after allogeneic hematopoietic stem cell transplantation as frequently…
Feature

Team-based approach before stem cell transplantation may improve outcomes for older adults

February 10, 2020
Evaluation by a multidisciplinary team clinic prior to hematopoietic stem cell transplantation appeared to reduce transplant-related morbidity and mortality among older…
In the JournalsPerspective

ASCO names refinement of surgical cancer treatment ‘Advance of the Year’

February 4, 2020
ASCO has named the refinement of surgical treatment of cancer as the Advance of the Year, recognizing emerging novel systemic therapies that changed the role of cancer…
More Headlines »
CME

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

More »
Video
Meeting News Coverage

VIDEO: CPX-351 improves outcomes for elderly patients with high-risk AML

June 20, 2016
More »